Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Inventory: 2019-2025

Historic Inventory for Sunshine Biopharma (SBFM) over the last 7 years, with Sep 2025 value amounting to $14.1 million.

  • Sunshine Biopharma's Inventory rose 43.20% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 43.20%. This contributed to the annual value of $11.3 million for FY2024, which is 96.66% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Inventory stood at $14.1 million, which was up 8.03% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Inventory ranged from a high of $14.1 million in Q3 2025 and a low of $26,660 during Q1 2021.
  • Moreover, its 3-year median value for Inventory was $8.5 million (2024), whereas its average is $8.6 million.
  • Data for Sunshine Biopharma's Inventory shows a peak YoY surged of 3,014.00% (in 2022) over the last 5 years.
  • Over the past 5 years, Sunshine Biopharma's Inventory (Quarterly) stood at $105,650 in 2021, then skyrocketed by 3,014.00% to $3.3 million in 2022, then surged by 74.31% to $5.7 million in 2023, then surged by 96.66% to $11.3 million in 2024, then skyrocketed by 43.20% to $14.1 million in 2025.
  • Its last three reported values are $14.1 million in Q3 2025, $13.0 million for Q2 2025, and $11.9 million during Q1 2025.